Sponsors 2026

Eos SENOLYTIX is a longevity company using MitoXcel™ Technology to develop novel therapeutics targeting the fundamental mechanisms of aging. Its lead clinical candidates, PTC-2105 and PTC-2107, both proprietary MitoXcel™ geropeptides, have demonstrated the ability to rejuvenate naturally aged mice via two separate mechanisms, both targeting the mitochondrial membrane potential (MMP), also called the “Δψm” (pronounced “delta psi em”), the difference in electrical potential between the mitochondrial matrix and the cytosol generated as protons are pumped out during the process of oxidative phosphorylation, during which the mitochondria “burn” carbohydrates, fats, and proteins, turning them into into ATP molecules, the packets of energy used by cells to fuel all of life’s processes, in the presence of oxygen.

For more information: www.eossenolytix.com

BlueOakNx is a Public Benefit Corporation on a mission to provide access to science-based, practitioner-grade nutraceuticals that enable a better quality of life from the inside out. The first product Mitokatylst™ - E is backed by 15 preclinical and clinical studies and 64 peer-reviewed papers. Mitokatlyst™ is the first targeted molecule clinically proven to induce mitochondrial biogenesis and boost cellular energy.

This promotes skeletal muscle strength, supports metabolic function, supports cardiovascular health, and stimulates a healthy inflammatory response. As of September of 2024, 14 more clinical trials and observational studies have been independently initiated at various universities in the US, Scotland, and Sweden. Co-founder Sundeep Dugar, PhD, also leads the $101M XPrize Healthspan Semifinalist team, A New Dimension.

Learn more at www.blueoaknx.com

Mitochondrial Research Needs a Shift: From Snapshots to Dynamics

Mitochondrial science is moving toward functional, real-time biology. Tools that capture dynamic cellular behavior are now essential.

Lucid Scientific’s platform, Resipher, enables continuous, non-invasive measurement of oxygen consumption directly inside standard incubators, with longitudinal profiling over hours to days.

Most metabolic assays still rely on static, endpoint measurements. Mitochondria operate dynamically, adapting continuously to stress, drugs, and signaling inputs.

Continuous oxygen consumption monitoring allows:

• Detection of transient metabolic shifts otherwise missed
• Improved reproducibility across experiments
• Refined analysis of drug response kinetics
• More accurate modeling of mitochondrial adaptation

At the Berlin congress, Lucid Scientific will present how real-time bioenergetics can refine mitochondrial phenotyping and accelerate translational workflows.

For more information about Lucid Scientific and the Resipher system :  lucidsci.com.